default author photo

Shin Kaneko

Kyoto University - Shin Kaneko Laboratory

Yoshida-Honmachi

Sakyo-ku

Kyoto, 606-8501

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

42

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity Via XCR1 + Dendritic Cells

Number of pages: 100 Posted: 27 Feb 2019
National Cancer Center, Japan - Division of Cancer Immunotherapy, National Cancer Center, Japan - Division of Cancer Immunotherapy, National Cancer Center, Japan - Division of Cancer Immunotherapy, Kyoto University - Shin Kaneko Laboratory, Aichi Cancer Center - Division of Immunology, Aichi Cancer Center - Division of Immunology, Kansai Medical University - Department of Stem Cell Biology and Regenerative Medicine, Rhelixa Inc., Rhelixa Inc., Yokohama City University - Department of Gastroenterological Surgery, Kumamoto University - Department of Dermatology and Plastic Surgery, Kumamoto University - Department of Dermatology and Plastic Surgery, Kumamoto University - Department of Dermatology and Plastic Surgery, Rhelixa Inc., National Center for Global Health and Medicine - Department of Stem Cell Biology, Kumamoto University - Division of Hematopoiesis, Kyoto University - Shin Kaneko Laboratory, Kumamoto University - Department of Dermatology and Plastic Surgery, Wakayama Medical University - Department of Immunology, Kumamoto University - Department of Immunogenetics, Kumamoto University - Department of Immunogenetics, Yokohama City University - Department of Gastroenterological Surgery, National Cancer Center, Japan - Division of Cancer Immunotherapy and National Cancer Center, Japan - Division of Cancer Immunotherapy
Downloads 42 (1,157,785)

Abstract:

Loading...

Cancer immunotherapy, iPS cell, type I interferon, XCR1, dendritic cells, cross-presentation, checkpoint blockade, PD-1, STING, CXCR3